TY - JOUR
T1 - A novel role of MNT as a negative regulator of REL and the NF-κB pathway
AU - Liaño-Pons, Judit
AU - Lafita-Navarro, M. Carmen
AU - García-Gaipo, Lorena
AU - Colomer, Carlota
AU - Rodríguez, Javier
AU - von Kriegsheim, Alex
AU - Hurlin, Peter J.
AU - Ourique, Fabiana
AU - Delgado, M. Dolores
AU - Bigas, Anna
AU - Espinosa, M. Lluis
AU - León, Javier
N1 - Funding Information:
The work was supported by grant SAF2017-88026-R from Agencia Estatal de Investigación, Spanish Government, to J.L. and M.D.D. J.L.-P. and M.C.L.-N. were recipients of F.P.U. fellowships and L.G.-G. of a F.P.I. fellowship from the Spanish Government. We are grateful to Jose P. Vaqué and Jose L. Fernandez-Luna for plasmids and antibodies, and Rosa Blanco, Victor Campa and Sandra Zunzunegui for technical help.
Publisher Copyright:
© 2021, The Author(s).
PY - 2021/1
Y1 - 2021/1
N2 - MNT, a transcription factor of the MXD family, is an important modulator of the oncoprotein MYC. Both MNT and MYC are basic-helix–loop–helix proteins that heterodimerize with MAX in a mutually exclusive manner, and bind to E-boxes within regulatory regions of their target genes. While MYC generally activates transcription, MNT represses it. However, the molecular interactions involving MNT as a transcriptional regulator beyond the binding to MAX remain unexplored. Here we demonstrate a novel MAX-independent protein interaction between MNT and REL, the oncogenic member of the NF-κB family. REL participates in important biological processes and it is altered in a variety of tumors. REL is a transcription factor that remains inactive in the cytoplasm in an inhibitory complex with IκB and translocates to the nucleus when the NF-κB pathway is activated. In the present manuscript, we show that MNT knockdown triggers REL translocation into the nucleus and thus the activation of the NF-κB pathway. Meanwhile, MNT overexpression results in the repression of IκBα, a bona fide REL target. Both MNT and REL bind to the IκBα gene on the first exon, suggesting its regulation as an MNT–REL complex. Altogether our data indicate that MNT acts as a repressor of the NF-κB pathway by two mechanisms: (1) retention of REL in the cytoplasm by MNT interaction, and (2) MNT-driven repression of REL-target genes through an MNT–REL complex. These results widen our knowledge about MNT biological roles and reveal a novel connection between the MYC/MXD and NF-κB pathways, two of the most prominent pathways in cancer.
AB - MNT, a transcription factor of the MXD family, is an important modulator of the oncoprotein MYC. Both MNT and MYC are basic-helix–loop–helix proteins that heterodimerize with MAX in a mutually exclusive manner, and bind to E-boxes within regulatory regions of their target genes. While MYC generally activates transcription, MNT represses it. However, the molecular interactions involving MNT as a transcriptional regulator beyond the binding to MAX remain unexplored. Here we demonstrate a novel MAX-independent protein interaction between MNT and REL, the oncogenic member of the NF-κB family. REL participates in important biological processes and it is altered in a variety of tumors. REL is a transcription factor that remains inactive in the cytoplasm in an inhibitory complex with IκB and translocates to the nucleus when the NF-κB pathway is activated. In the present manuscript, we show that MNT knockdown triggers REL translocation into the nucleus and thus the activation of the NF-κB pathway. Meanwhile, MNT overexpression results in the repression of IκBα, a bona fide REL target. Both MNT and REL bind to the IκBα gene on the first exon, suggesting its regulation as an MNT–REL complex. Altogether our data indicate that MNT acts as a repressor of the NF-κB pathway by two mechanisms: (1) retention of REL in the cytoplasm by MNT interaction, and (2) MNT-driven repression of REL-target genes through an MNT–REL complex. These results widen our knowledge about MNT biological roles and reveal a novel connection between the MYC/MXD and NF-κB pathways, two of the most prominent pathways in cancer.
UR - http://www.scopus.com/inward/record.url?scp=85098955028&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85098955028&partnerID=8YFLogxK
U2 - 10.1038/s41389-020-00298-4
DO - 10.1038/s41389-020-00298-4
M3 - Article
C2 - 33419981
AN - SCOPUS:85098955028
SN - 2157-9024
VL - 10
JO - Oncogenesis
JF - Oncogenesis
IS - 1
M1 - 5
ER -